http://www.ons.org/NewsNews from the Oncology Nursing Societyen-usDeborah Braccia, DNSc, MPA, RN, OCN(R)Deborah Braccia, DNSc, MPA, RN, OCN(R)http://www.ons.org/News.aspx?id=279Awards GrantedThe Oncology Nursing Certification Corporation (ONCC) has selected Georgia “Georgie” Cusack, MS, RN, AOCNS®, as the 2013 Advanced Oncology Certified Nurse of the Year. Cusack was selected for the award based on her contributions to oncology nursing and oncology nursing service, and for supporting and promoting certification in oncology nursing. 2013-05-03T00:00:00-04:00http://www.ons.org/news.aspx?id=279http://www.ons.org/News.aspx?id=281Awards GrantedThe Oncology Nursing Certification Corporation (ONCC) has selected Marsha Richardson, RN, MSN, OCN®, CBCN® as the 2013 Certified Breast Care Nurse of the Year. Richardson was selected for the award for her contributions to breast care nursing and nursing service; and for supporting and promoting certification in breast care/oncology nursing. She is the oncology program coordinator/breast cancer navigator at Parrish Medical Center in Titusville, FL. 2013-05-03T00:00:00-04:00http://www.ons.org/news.aspx?id=281http://www.ons.org/News.aspx?id=282Awards GrantedThe Oncology Nursing Certification Corporation (ONCC) has named Saint Peter’s University Hospital in New Brunswick, NJ, as the recipient of its 2013 Employer Recognition Award. Each year, this award recognizes one institution that employs 25 or more registered nurses for providing sustained support of oncology nursing certification. 2013-05-03T00:00:00-04:00http://www.ons.org/news.aspx?id=282http://www.ons.org/News.aspx?id=280Awards GrantedThe Oncology Nursing Certification Corporation (ONCC) has selected Janine Kokal, MS, RN, OCN®, as the 2013 Oncology Certified Nurse of the Year. Kokal was selected for the award for her contributions to oncology nursing and oncology nursing service and for supporting and promoting certification in oncology nursing. She is an educator with the Mayo Clinic Cancer Education Program in Rochester, MN.2013-05-03T00:00:00-04:00http://www.ons.org/news.aspx?id=280http://www.ons.org/News.aspx?id=277ONS NewsThe Oncology Nursing Society (ONS) announced its 2013–2014 Board of Directors at its 38th Annual Congress in Washington, DC. 2013-04-27T00:00:00-04:00http://www.ons.org/news.aspx?id=277http://www.ons.org/News.aspx?id=278ONS NewsThe Oncology Nursing Society (ONS) honored the following award recipients during the opening ceremony of the ONS 38th Annual Congress in Washington, DC. 2013-04-25T00:00:00-04:00http://www.ons.org/news.aspx?id=278http://www.ons.org/News.aspx?id=273ONS NewsSeveral exciting new features are now available on the expanded preview of ONS's redesigned website. You asked, and we listened. In response to your feedback, ONS has been in the process of redesigning our website from the ground up. Because we care about the best interests of oncology nurses, we've looked at your questions, comments, and usage data to design a site entirely focused on helping you get to the information you need as quickly and easily as possible. Check out the expanded preview site on any device.2013-04-08T00:00:00-04:00http://www.ons.org/news.aspx?id=273http://www.ons.org/News.aspx?id=271ONS NewsIn response to member feedback, ONS is in the process of redesigning our website from the ground up to offer a site entirely focused on helping oncology nurses get to the information they need as quickly and easily as possible. The launch of two exciting developments in this process is right around the corner: a brand-new ONS profile site, as well as an expanded beta preview of our new website. More details will be available in April when each of these launches. 2013-03-19T00:00:00-04:00http://www.ons.org/news.aspx?id=271http://www.ons.org/News.aspx?id=270ONS NewsThe Oncology Nursing Society (ONS) is pleased to announce that Self-Healing Through Reflection, A Workbook for Nurses published by Hygeia Media, an imprint of ONS, won second place in the prestigious 2012 American Journal of Nursing (AJN) Book of the Year Award in the professional development and issues category. 2013-01-25T00:00:00-05:00http://www.ons.org/news.aspx?id=270http://www.ons.org/News.aspx?id=267ONS NewsAs cancer care is delivered more often in ambulatory settings or during very short hospital stays, the role of family members and other caregivers is becoming increasingly important in the care of patients with cancer. The Oncology Nursing Society (ONS) has received a three-year grant from the Agency for Healthcare Research and Quality (AHRQ) to develop and examine innovative electronic communication methods to disseminate ONS’s research-based resources to healthcare providers to help improve the quality of patient care. 2013-01-15T00:00:00-05:00http://www.ons.org/news.aspx?id=267http://www.ons.org/News.aspx?id=266ONS NewsOncology nurses’ understanding and application of cancer genetics and genomics can change and improve the practice of general oncology nurses and advanced practice nurses in the course of patient risk assessment, prevention, screening, and treatment of cancer. A new position released by the Oncology Nursing Society (ONS) encourages the integration of new evidence-based genetic and genomic information into oncology nursing practice and the education of patients and the public about the potential benefits and limitations of genetic and genomic testing.2013-01-10T00:00:00-05:00http://www.ons.org/news.aspx?id=266http://www.ons.org/News.aspx?id=265ONS NewsThe Oncology Nursing Society (ONS) is pleased to announce that it has selected the Schoology platform as its preferred learning management system. ONS will use Schoology to connect members to its latest research, training, and continuing education resources. 2012-12-20T00:00:00-05:00http://www.ons.org/news.aspx?id=265http://www.ons.org/News.aspx?id=264FDA UpdatesThe U.S. Food and Drug Administration granted accelerated approval to ponatinib (Iclusig™ tablets, ARIAD Pharmaceuticals, Inc.) for the treatment of adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL) that is resistant or intolerant to prior tyrosine kinase inhibitor therapy. 2012-12-14T00:00:00-05:00http://www.ons.org/news.aspx?id=264http://www.ons.org/News.aspx?id=263FDA UpdatesThe U.S. Food and Drug Administration approved an expanded indication for abiraterone acetate (Zytiga® Tablets, Janssen Biotech, Inc.) in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer. 2012-12-10T00:00:00-05:00http://www.ons.org/news.aspx?id=263http://www.ons.org/News.aspx?id=262FDA UpdatesThe U.S. Food and Drug Administration approved cabozantinib (COMETRIQ™ capsules, Exelixis, Inc), for the treatment of patients with progressive metastatic medullary thyroid cancer (MTC). 2012-11-29T00:00:00-05:00http://www.ons.org/news.aspx?id=262http://www.ons.org/News.aspx?id=261ONS NewsNurses are the largest profession of healthcare workers in the United States and are at the forefront of patient care. In today’s complex healthcare delivery environment, nurses must be leaders at all levels of the profession. The Oncology Nursing Society (ONS) is pleased to announce the release of the ONS Leadership Competencies which are designed to reflect the specific needs of oncology nurses, but can transcend practice settings and be used universally across nursing specialties to increase and measure leadership competency in any environment.2012-11-14T00:00:00-05:00http://www.ons.org/news.aspx?id=261http://www.ons.org/News.aspx?id=260ONS NewsStarting in November 2012, advanced print exclusive articles for CJON will be available on MetaPress under the advanced print exclusive tab. These articles will be open access, meaning they are available to members and non-members alike, until they appear in print at a later date. At that time, the content will become password-protected like all of the other articles that appear in print as online exclusives in the journals.2012-11-08T00:00:00-05:00http://www.ons.org/news.aspx?id=260http://www.ons.org/News.aspx?id=257FDA UpdatesThe U.S. Food and Drug Administration (FDA) granted accelerated approval to omacetaxine mepesuccinate, (SYNRIBO® for Injection, for subcutaneous use, Teva Pharmaceutical Industries Ltd.), for the treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia (CML) with resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKIs). 2012-10-26T00:00:00-04:00http://www.ons.org/news.aspx?id=257http://www.ons.org/News.aspx?id=256FDA UpdatesThe U.S. Food and Drug Administration approved a 90-minute infusion for rituximab (Rituxan® Injection, Genentech, Inc.) starting at Cycle 2 for patients with non-Hodgkin’s lymphoma (NHL) who did not experience a grade 3 or 4 infusion-related adverse reaction during Cycle 1. 2012-10-19T00:00:00-04:00http://www.ons.org/news.aspx?id=256http://www.ons.org/News.aspx?id=255FDA UpdatesThe U.S. Food and Drug Administration expanded labeling to include the results of an additional trial evaluating the safety and efficacy of pemetrexed (ALIMTA®, Eli Lilly and Company) for the initial treatment of patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer followed by pemetrexed maintenance in patients whose disease has not progressed after four cycles of platinum and pemetrexed as first-line chemotherapy.2012-10-17T00:00:00-04:00http://www.ons.org/news.aspx?id=255http://www.ons.org/News.aspx?id=254FDA UpdatesThe US Food and Drug Administration approved paclitaxel protein-bound particles for injectable suspension, albumin-bound (ABRAXANE® for Injectable Suspension; Abraxis Bioscience a wholly owned subsidiary of Celgene Corporation) for use in combination with carboplatin for the initial treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who are not candidates for curative surgery or radiation therapy.2012-10-11T00:00:00-04:00http://www.ons.org/news.aspx?id=254http://www.ons.org/News.aspx?id=253ONS NewsThe ONS Foundation has awarded Marie Flannery, PhD, RN, AOCN®, a $10,000 Trish Greene Pain Assessment and Management Research Grant, sponsored by Purdue Pharma L.P. 2012-10-10T00:00:00-04:00http://www.ons.org/news.aspx?id=253http://www.ons.org/News.aspx?id=252ONS NewsThe Oncology Nursing Society (ONS) is pleased to announce that the journals Oncology Nursing Forum (ONF) and Clinical Journal of Oncology Nursing (CJON) are unveiling advanced print exclusive articles to give readers access to important, cutting-edge content ahead of print. 2012-10-09T00:00:00-04:00http://www.ons.org/news.aspx?id=252http://www.ons.org/News.aspx?id=251FDA UpdatesThe U.S. Food and Drug Administration approved regorafenib (Stivarga® tablets, Bayer HealthCare Pharmaceuticals, Inc.), for the treatment of patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if KRAS wild type, an anti-EGFR therapy.2012-09-27T00:00:00-04:00http://www.ons.org/news.aspx?id=251http://www.ons.org/News.aspx?id=250ONS NewsHealth information technology (HIT) improves the quality of healthcare delivery, increases patient safety, decreases medical errors, and strengthens the interaction between patients and healthcare providers. 2012-09-11T00:00:00-04:00http://www.ons.org/news.aspx?id=250http://www.ons.org/News.aspx?id=248ONS NewsThe Oncology Nursing Society’s (ONS) Seal of Approval program is designed to assist healthcare professionals and consumers in selecting quality educational materials related to cancer care. 2012-09-07T00:00:00-04:00http://www.ons.org/news.aspx?id=248http://www.ons.org/News.aspx?id=249ONS NewsThe Oncology Nursing Society (ONS) welcomes Millennium: The Takeda Oncology Company as a co-sponsor of the ONS Honor Someone Special recognition program. 2012-09-07T00:00:00-04:00http://www.ons.org/news.aspx?id=249http://www.ons.org/News.aspx?id=247FDA UpdatesThe U.S. Food and Drug Administration (FDA) approved bosutinib tablets (Bosulif®, Pfizer, Inc.) for the treatment of chronic, accelerated, or blast phase Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML) in adult patients with resistance or intolerance to prior therapy. 2012-09-04T00:00:00-04:00http://www.ons.org/news.aspx?id=247http://www.ons.org/News.aspx?id=246FDA UpdatesThe U.S. Food and Drug Administration (FDA) approved enzalutamide (XTANDI® Capsules, Medivation, Inc. and Astellas Pharma US, Inc.), for the treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel. 2012-08-31T00:00:00-04:00http://www.ons.org/news.aspx?id=246http://www.ons.org/News.aspx?id=245FDA UpdatesThe U.S. Food and Drug Administration granted accelerated approval for everolimus tablets for oral suspension (Afinitor Disperz®, Novartis Pharmaceuticals Corp.) for the treatment of pediatric and adult patients with tuberous sclerosis complex (TSC) who have subependymal giant cell astrocytoma (SEGA) that requires therapeutic intervention but cannot be curatively resected. 2012-08-29T00:00:00-04:00http://www.ons.org/news.aspx?id=245http://www.ons.org/News.aspx?id=244ONS NewsThe Oncology Nursing Certification Corporation (ONCC) announces it will offer a new certification program in blood and marrow transplantation (BMT) nursing. The first Blood and Marrow Transplantation Certified Nurse Examination will be offered in February 2014. Nurses who pass the test will earn the credential “BMTCN.”2012-08-24T00:00:00-04:00http://www.ons.org/news.aspx?id=244http://www.ons.org/News.aspx?id=243ONS NewsThe American Medical Writers Association (AMWA) has recognized the Oncology Nursing Society (ONS) with an Honorable Mention award for the book Nursing Management: Principles and Practice, 2nd ed. in the Non-Physician Category. 2012-08-20T00:00:00-04:00http://www.ons.org/news.aspx?id=243http://www.ons.org/News.aspx?id=241FDA UpdatesThe U.S. Food and Drug Administration (FDA) granted accelerated approval for vinCRIStine sulfate LIPOSOME injection (Marqibo®, Talon Therapeutics, Inc.) for the treatment of adult patients with Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL) in second or greater relapse or whose disease has progressed following two or more anti-leukemia therapies.2012-08-09T00:00:00-04:00http://www.ons.org/news.aspx?id=241http://www.ons.org/News.aspx?id=242ONS NewsNurses want—and need—quality radiation education without the high costs of travel. That’s exactly what the Oncology Nursing Society (ONS) Radiation eConference delivers. 2012-08-09T00:00:00-04:00http://www.ons.org/news.aspx?id=242http://www.ons.org/News.aspx?id=240FDA UpdatesThe U.S. Food and Drug Administration approved ziv-aflibercept injection (ZALTRAP®, Sanofi U.S., Inc.) for use in combination with 5-fluorouracil, leucovorin, irinotecan (FOLFIRI) for the treatment of patients with metastatic colorectal cancer (mCRC) that is resistant to or has progressed following an oxaliplatin containing regimen.2012-08-03T00:00:00-04:00http://www.ons.org/news.aspx?id=240http://www.ons.org/News.aspx?id=239FDA UpdatesThe U.S. Food and Drug Administration (FDA) approved everolimus tablets (Afinitor®, Novartis Pharmaceuticals Corporation) for the treatment of postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer in combination with exemestane, after failure of treatment with letrozole or anastrozole. 2012-07-20T00:00:00-04:00http://www.ons.org/news.aspx?id=239http://www.ons.org/News.aspx?id=238FDA UpdatesThe U.S. Food and Drug Administration (FDA) granted accelerated approval to carfilzomib injection (Kyprolis™, Onyx Pharmaceuticals), for the treatment of patients with multiple myeloma who have received at least two prior therapies, including bortezomib and an immunomodulatory agent, and have demonstrated disease progression on or within 60 days of the completion of the last therapy. 2012-07-20T00:00:00-04:00http://www.ons.org/news.aspx?id=238http://www.ons.org/News.aspx?id=236Press ReleasesONS has joined forces with the American Nurses Association (ANA) and other nursing groups to support Joining Forces, a nonpartisan national initiative led by the White House and First Lady Michelle Obama to mobilize all sectors of the community to support service members and their families.2012-07-12T00:00:00-04:00http://www.ons.org/news.aspx?id=236http://www.ons.org/News.aspx?id=237ONS NewsThe Oncology Nursing Society (ONS) is pleased to announce that it has been granted full membership into the Alliance for Nursing Informatics (ANI). ANI is a collaboration of organizations that represents more than 5,000 nurse informaticists and brings together 30 distinct nursing informatics groups globally. 2012-07-12T00:00:00-04:00http://www.ons.org/news.aspx?id=237http://www.ons.org/News.aspx?id=235ONS NewsAccess to quality cancer care is the right of all people. A new position released by the Oncology Nursing Society (ONS) affirms that affordable and accessible comprehensive healthcare coverage with respect to cancer prevention, early detection, risk assessment, and other factors should be available to everyone regardless of personal or family history or preexisting conditions.2012-07-10T00:00:00-04:00http://www.ons.org/news.aspx?id=235http://www.ons.org/News.aspx?id=234FDA UpdatesThe U.S. Food and Drug Administration granted approval to cetuximab (Erbitux®, ImClone LLC, a wholly owned subsidiary of Eli Lilly and Co) for use in combination with FOLFIRI (irinotecan, 5-fluorouracil, leucovorin) for first-line treatment of patients with K-ras mutation-negative (wild-type), EGFR-expressing metastatic colorectal cancer (mCRC) as determined by FDA-approved tests for this use. FDA also approved the Therascreen® KRAS RGQ PCR Kit (QIAGEN Manchester, Ltd) concurrent with this cetuximab approval. 2012-07-06T00:00:00-04:00http://www.ons.org/news.aspx?id=234http://www.ons.org/News.aspx?id=233ONS NewsThe Oncology Nursing Society (ONS) is pleased to announce that the Oncology Nursing Forum (ONF) is ranked first for impact factor among 97 journals in the nursing category from 2011 Journal Citation Reports® (Thomson Reuters, 2011). The impact factor measures the number of times that articles within a particular journal are cited, thereby measuring the impact that they have on the literature. 2012-07-05T00:00:00-04:00http://www.ons.org/news.aspx?id=233http://www.ons.org/News.aspx?id=232Awards GrantedBeth Faiman, MSN, APRN-BC, AOCN®, is the recipient of the 2012 Oncology Nursing Society (ONS) Excellence in Medical Oncology Award. Faiman is a nurse practitioner at Cleveland Clinic and a PhD candidate at the Frances Payne Bolton School of Nursing at Case Western Reserve University in Cleveland, OH. 2012-07-03T00:00:00-04:00http://www.ons.org/news.aspx?id=232http://www.ons.org/News.aspx?id=231Awards GrantedWendy Vogel, MSN, FNP, AOCNP® is the recipient of the Oncology Nursing Society (ONS) Mary Nowotny Excellence in Cancer Nursing Education Award for 2012. Vogel is an oncology nurse practitioner at Kingsport Hematology Oncology Associates in Kingsport, TN. 2012-07-03T00:00:00-04:00http://www.ons.org/news.aspx?id=231http://www.ons.org/News.aspx?id=230ONS NewsThe Oncology Nursing Society (ONS) was honored for its publishing excellence by Association Media & Publishing (AMP) at AMP’s annual Awards Gala. 2012-06-15T00:00:00-04:00http://www.ons.org/news.aspx?id=230http://www.ons.org/News.aspx?id=228Awards Granted– Elizabeth Lee Krayk, RN, BSN, OCN®, is the recipient of the 2012 Oncology Nursing Society (ONS) Pearl Moore “Making a Difference” Frontline Care Award. She is an RN, clinical nurse III at Renown Regional Medical Center in Reno, NV. This award recognizes her as a frontline oncology nurse who demonstrates exceptional patient care through the use of evidence-based practice.2012-06-13T00:00:00-04:00http://www.ons.org/news.aspx?id=228http://www.ons.org/News.aspx?id=227FDA UpdatesThe U.S. Food and Drug Administration approved pertuzumab injection (PERJETA™, Genentech, Inc.) for use in combination with trastuzumab and docetaxel for the treatment of patients with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease. Pertuzumab is a recombinant humanized monoclonal antibody that targets the extracellular dimerization domain (Subdomain II) of HER2, and thereby blocks ligand-dependent heterodimerization of HER2 with other HER family members, including EGFR, HER3 and HER4. 2012-06-08T00:00:00-04:00http://www.ons.org/news.aspx?id=227http://www.ons.org/News.aspx?id=226Awards GrantedMichelle Wallace, RN, BSN, OCN®, is the recipient of the 2012 Oncology Nursing Society (ONS) Excellence in Radiation Therapy Nursing Award. Wallace is a nurse clinician in radiation oncology at Beaumont Health System in Royal Oak, MI. This award recognizes her as an expert oncology nurse in the field of radiation oncology who made significant contributions to the field through outstanding patient care. 2012-06-07T00:00:00-04:00http://www.ons.org/news.aspx?id=226http://www.ons.org/News.aspx?id=225Awards GrantedJill M. Reese, RN, BSN, OCN®, is the recipient of the 2012 Oncology Nursing Society (ONS) Excellence in Patient/Public Education Award. Reese is a clinical educator at Dayton Physicians, LLC, in Dayton, OH. This award recognizes her as an oncology nurse involved in offering creative and innovative educational programming for her patients, their families, and her community. 2012-06-06T00:00:00-04:00http://www.ons.org/news.aspx?id=225http://www.ons.org/News.aspx?id=224Awards GrantedThe Community Outreach Committee of the Columbus Chapter of the Oncology Nursing Society (CCONS) is the 2012 recipient of the Pearl Moore “Making a Difference” Team Achievement Award. This award recognizes outstanding contributions within the workplace in improving patient care or making a difference in the community.2012-05-31T00:00:00-04:00http://www.ons.org/news.aspx?id=224http://www.ons.org/News.aspx?id=223Awards GrantedAyda G. Nambayan, DSN, RN, is the 2012 recipient of the Oncology Nursing Society (ONS) Pearl Moore International Award for Contributions to Cancer Care. Nambayan is Consultant for Advanced Education and Professional Training and Director of Nursing Education and Research at The Cancer Center, Makati Medical Center, in Manila, Philippines.2012-05-29T00:00:00-04:00http://www.ons.org/news.aspx?id=223http://www.ons.org/News.aspx?id=222Awards GrantedSusan Larsen Beck, PhD, APRN, AOCN®, FAAN, has been named the Oncology Nursing Society’s (ONS) 2012 Distinguished Researcher. Beck is Professor and Robert S. and Beth M. Carter Endowed Chair in Nursing at the University of Utah College of Nursing in Salt Lake City. The honor recognizes her outstanding research contributions that have enhanced the science and practice of oncology nursing. 2012-05-29T00:00:00-04:00http://www.ons.org/news.aspx?id=222http://www.ons.org/News.aspx?id=221Awards GrantedPatricia Frank, RN, BSN, is the recipient of the 2012 Oncology Nursing Society (ONS) Pearl Moore “Making a Difference” Emerging Leader Award. This award recognizes her as an emerging oncology nurse leader who has made a difference in the oncology nursing profession at the local or regional level. 2012-05-18T00:00:00-04:00http://www.ons.org/news.aspx?id=221http://www.ons.org/News.aspx?id=219Awards GrantedAnna Schwartz, PhD, FNP, FAAN, of Wilson, WY, associate professor at Idaho State University in Pocatello and affiliate professor at the University of Washington in Seattle, is the recipient of the Oncology Nursing Society (ONS) 2012 Rose Mary Carroll-Johnson Distinguished Award for Consistent Contribution to the Nursing Literature. 2012-05-16T00:00:00-04:00http://www.ons.org/news.aspx?id=219http://www.ons.org/News.aspx?id=220Awards GrantedLaura Wood, RN, MSN, OCN®, presented the 2012 Oncology Nursing Society (ONS) Clinical Lecture at the ONS 37th Annual Congress which was held May 3-6 in New Orleans, LA. 2012-05-16T00:00:00-04:00http://www.ons.org/news.aspx?id=220http://www.ons.org/News.aspx?id=218Awards GrantedThe Oncology Nursing Certification Corporation (ONCC) has selected Kelly Smith, MSN, RN, NP, AOCN® as the 2012 Advanced Oncology Certified Nurse of the Year. Smith was selected for the award for her contributions to oncology nursing and oncology nursing service; and for supporting and promoting certification in oncology nursing. 2012-05-11T00:00:00-04:00http://www.ons.org/news.aspx?id=218http://www.ons.org/News.aspx?id=215Awards GrantedThe Oncology Nursing Certification Corporation (ONCC) has named Froedtert Hospital in Milwaukee, WI, as a recipient of its 2012 Employer Recognition Award. Each year, this award recognizes one institution that employs 25 or more registered nurses for providing sustained support of oncology nursing certification. 2012-05-11T00:00:00-04:00http://www.ons.org/news.aspx?id=215http://www.ons.org/News.aspx?id=216Awards GrantedThe Oncology Nursing Certification Corporation (ONCC) has selected Moncrief Cancer Institute in Fort Worth, TX, as a recipient of its 2012 Employer Recognition Award. Each year, this award recognizes one organization that employs less than 25 registered nurses for providing sustained support of certification in oncology nursing. 2012-05-11T00:00:00-04:00http://www.ons.org/news.aspx?id=216http://www.ons.org/News.aspx?id=217Awards GrantedThe Oncology Nursing Certification Corporation (ONCC) has selected Sylvia Danko, RN, BSN, OCN®, CBCN® as the 2012 Oncology Certified Nurse of the Year. Danko was selected for the award for her contributions to oncology nursing and oncology nursing service, and for supporting and promoting certification in oncology nursing. 2012-05-11T00:00:00-04:00http://www.ons.org/news.aspx?id=217http://www.ons.org/News.aspx?id=229ONS NewsThe Oncology Nursing Society (ONS) announced its 2012–2013 Board of Directors at its 37th Annual Congress in New Orleans, LA. 2012-05-05T00:00:00-04:00http://www.ons.org/news.aspx?id=229http://www.ons.org/News.aspx?id=214FDA UpdatesThe U.S. Food and Drug Administration approved pazopanib tablets (VOTRIENT®, a registered Trademark of GlaxoSmithKline) for the treatment of patients with advanced soft tissue sarcoma (STS) who have received prior chemotherapy. 2012-04-26T00:00:00-04:00http://www.ons.org/news.aspx?id=214http://www.ons.org/News.aspx?id=213FDA UpdatesThe U.S. Food and Drug Administration granted accelerated approval to everolimus (Afinitor tablets, Novartis) for the treatment of adults with renal angiomyolipoma, associated with tuberous sclerosis complex (TSC), who do not require immediate surgery. 2012-04-26T00:00:00-04:00http://www.ons.org/news.aspx?id=213http://www.ons.org/News.aspx?id=212Awards GrantedThe Oncology Nursing Society (ONS) has selected The Regional Cancer Center (RCC) in Erie, PA, as the recipient of its 2012 Employer Recognition Award for medium-sized employers. This award recognizes employers who show exemplary support of their registered nurses working in oncology. The award will be presented during ONS’s 37th Annual Congress in New Orleans, LA, on May 3–6.2012-04-18T00:00:00-04:00http://www.ons.org/news.aspx?id=212http://www.ons.org/News.aspx?id=210ONS NewsThe Oncology Nursing Society (ONS) is proud to be part of an international initiative that outlines an innovative model to address a wide range of physical issues faced by women with breast cancer and offers hope for improved function and full participation in life activities for patients through rehabilitation and exercise.2012-04-11T00:00:00-04:00http://www.ons.org/news.aspx?id=210http://www.ons.org/News.aspx?id=211Awards GrantedCarol Reed Ash, EdD, RN, FAAN, is the recipient of the 2012 Oncology Nursing Society (ONS) Lifetime Achievement Award. Ash is professor emeritus, Kirbo Endowed Chair, Oncology Nursing at the University of Florida in Gainesville. The award recognizes her outstanding contributions as an oncology nurse researcher, mentor, and educator as well as her service to ONS and the community at large. 2012-04-05T00:00:00-04:00http://www.ons.org/news.aspx?id=211http://www.ons.org/News.aspx?id=208Awards GrantedDonna Berry, PhD, RN, AOCN®, FAAN, is the recipient of an ONS Foundation Endowment Nursing Research Grant for her project entitled, “ESRA-C Spanish: Linguistic Appropriateness and Cultural Sensitivity.” 2012-03-22T00:00:00-04:00http://www.ons.org/news.aspx?id=208http://www.ons.org/News.aspx?id=207Legislative UpdatesToday, the U.S. Preventive Services Task Force posted its final recommendation statement on screening for cervical cancer. 2012-03-16T00:00:00-04:00http://www.ons.org/news.aspx?id=207http://www.ons.org/News.aspx?id=204Legislative UpdatesCMS Offers Insight to Colorectal Cancer Awareness Month in March. Of cancers that affect both men and women, colorectal cancer is the second leading cause of cancer-related deaths in the United States and the third most common cancer in men and in women.2012-03-09T00:00:00-05:00http://www.ons.org/news.aspx?id=204http://www.ons.org/News.aspx?id=205ONS NewsCancer care is rapidly changing, and nurses who care for patients with cancer must commit to lifelong learning to have the expert skills and knowledge they need to provide quality cancer care to their patients. The Oncology Nursing Society (ONS) has released a new position statement on this topic.2012-03-09T00:00:00-05:00http://www.ons.org/news.aspx?id=205http://www.ons.org/News.aspx?id=203Legislative UpdatesOn February 29, DC District Judge Richard Leon overturned a lower Court’s decision allowing the FDA’s graphic labeling of tobacco products.2012-03-02T00:00:00-05:00http://www.ons.org/news.aspx?id=203http://www.ons.org/News.aspx?id=206Awards GrantedThe Oncology Nursing Society (ONS) has selected Moffitt Cancer Center in Tampa, FL, as the recipient of its 2012 Employer Recognition Award for large employers.2012-03-01T00:00:00-05:00http://www.ons.org/news.aspx?id=206http://www.ons.org/News.aspx?id=202ONS NewsThe Oncology Nursing Certification Corporation (ONCC) received accreditation of its Certified Pediatric Hematology Oncology Nurse (CPHON®) program from the National Commission for Certifying Agencies (NCCA). The accreditation is valid through April 30, 2015.2012-02-22T00:00:00-05:00http://www.ons.org/news.aspx?id=202http://www.ons.org/News.aspx?id=201FDA UpdatesThe FDA announces major actions taken to bolster the supply of Doxil® (Janssen Research & Development LLC.) and preservative-free formulations of methotrexate. 2012-02-21T00:00:00-05:00http://www.ons.org/news.aspx?id=201http://www.ons.org/News.aspx?id=200ONS NewsThe Oncology Nursing Society (ONS) with Representative Steve Israel (D-NY) announced today the unveiling of his legislation, HR 3790, “The Improving Cancer Treatment Education Act of 2012.” The announcement was made at a special event at Huntington Hospital in Long Island, NY. 2012-02-21T00:00:00-05:00http://www.ons.org/news.aspx?id=200http://www.ons.org/News.aspx?id=199ONS NewsONS's award-winning publishing division is pleased to announce that it has received an award from the Professional and Scholarly Publishing Division of the Association of American Publishers.2012-02-13T00:00:00-05:00http://www.ons.org/news.aspx?id=199http://www.ons.org/News.aspx?id=198FDA UpdatesThe U.S. Food and Drug Administration (FDA) granted regular approval for imatinib mesylate tablets (Gleevec®, Novartis Pharmaceuticals) for the adjuvant treatment of adult patients following complete gross resection of Kit (CD117) positive Gastrointestinal Stromal Tumors (GIST). 2012-01-31T00:00:00-05:00http://www.ons.org/news.aspx?id=198http://www.ons.org/News.aspx?id=197FDA UpdatesThe U.S. Food and Drug Administration approved vismodegib (ERIVEDGE™ Capsule, Genentech, Inc.) for the treatment of adults with metastatic basal cell carcinoma or with locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery, and who are not candidates for radiation. 2012-01-30T00:00:00-05:00http://www.ons.org/news.aspx?id=197http://www.ons.org/News.aspx?id=196FDA UpdatesThe U.S. Food and Drug Administration approved axitinib tablets (Inlyta, Pfizer, Inc.) for the treatment of advanced renal cell carcinoma after failure of one prior systemic therapy.2012-01-27T00:00:00-05:00http://www.ons.org/news.aspx?id=196http://www.ons.org/News.aspx?id=195ONS NewsThe American Journal of Nursing (AJN) has awarded the prestigious 2011 AJN Book of the Year Award to the Oncology Nursing Society (ONS) for Advanced Oncology Nursing Certification Review and Resource Manual: Instructor’s Resource, edited by Shirley Triest-Robinson, RN, PhD, AOCNS®, ACNS B, and Wendy H. Vogel, MSN, FNP, AOCNP®, in the Electronic Media category.2012-01-26T00:00:00-05:00http://www.ons.org/news.aspx?id=195http://www.ons.org/News.aspx?id=194ONS NewsThe Oncology Nursing Society (ONS) is pleased to announce Anne Katz, RN, PhD, as the new editor of the Oncology Nursing Forum (ONF), the Society’s flagship journal. Katz will begin her new responsibility on March 1.2012-01-25T00:00:00-05:00http://www.ons.org/news.aspx?id=194http://www.ons.org/News.aspx?id=193Legislative UpdatesA resolution recognizing the 40th anniversary of the National Cancer Act of 1971 and the more than 12,000,000 survivors of cancer alive today because of the commitment of the United States to cancer research and advances in cancer prevention, detection, diagnosis, and treatment.2012-01-19T00:00:00-05:00http://www.ons.org/news.aspx?id=193http://www.ons.org/News.aspx?id=192FDA UpdatesThe US Food and Drug Administration approved glucarpidase injection (Voraxaze®, BTG International Inc.) for the treatment of toxic plasma methotrexate concentrations (> 1 µmol/L) in patients with delayed methotrexate clearance due to impaired renal function.2012-01-17T00:00:00-05:00http://www.ons.org/news.aspx?id=192http://www.ons.org/News.aspx?id=189FDA UpdatesThe US Food and Drug Administration has approved changes to the package inserts for methotrexate products for intravenous administration. 2011-12-21T00:00:00-05:00http://www.ons.org/news.aspx?id=189http://www.ons.org/News.aspx?id=188ONS NewsThe Oncology Nursing Society (ONS) recently hosted a groundbreaking HIT Think Tank in Pittsburgh, PA, to assess ways to support their members as HIT becomes more a part of everyday life in healthcare organizations. 2011-12-15T00:00:00-05:00http://www.ons.org/news.aspx?id=188http://www.ons.org/News.aspx?id=187Legislative UpdatesONS congratulates Lt. General Horoho on her confirmation as the newest Surgeon General of the US Army.2011-12-14T00:00:00-05:00http://www.ons.org/news.aspx?id=187http://www.ons.org/News.aspx?id=186ONS NewsNurses who are certified by the Oncology Nursing Certification Corporation (ONCC) will soon have a new method for renewing their certification credentials. 2011-12-09T00:00:00-05:00http://www.ons.org/news.aspx?id=186http://www.ons.org/News.aspx?id=184Legislative UpdatesThe US Senate Finance Committee holds hearing on the national drug shortage.2011-12-07T00:00:00-05:00http://www.ons.org/news.aspx?id=184http://www.ons.org/News.aspx?id=183FDA UpdatesThe Food and Drug Administration (FDA) approved changes to the Risk Evaluation and Mitigation Strategies (REMS) for romiplostim (Nplate for subcutaneous injection, Amgen Inc.) and eltrombopag (Promacta tablets, GlaxoSmithKline LLC) to remove the restricted distribution programs and the safety reporting requirements that were part of the REMS. Prescriber, institution, pharmacy, and patient enrollment and these data collection requirements are no longer necessary. 2011-12-06T00:00:00-05:00http://www.ons.org/news.aspx?id=183http://www.ons.org/News.aspx?id=182Legislative UpdatesA new effort to help teens quit smoking will use one of today's teen's most constant companions - the mobile phone. Developed by smoking cessation experts, SmokefreeTXT is a free text message cessation service that provides 24/7 encouragement, advice, and tips to teens trying to quit smoking.2011-12-05T00:00:00-05:00http://www.ons.org/news.aspx?id=182http://www.ons.org/News.aspx?id=181ONS NewsThe ONS Foundation and the Cancer Support Community (CSC) are advancing the understanding of the needs of, and treatment for, breast cancer survivors through two multi-year projects, both funded by The Breast Cancer Fund of National Philanthropic Trust starting in 2009. 2011-11-22T00:00:00-05:00http://www.ons.org/news.aspx?id=181http://www.ons.org/News.aspx?id=178FDA UpdatesThe US Food and Drug Administration approved asparaginase Erwinia chrysanthemi [ErwinazeTM, injection, EUSA Pharma (USA), Inc.] as a component of a multi-agent chemotherapeutic regimen for the treatment of patients with acute lymphoblastic leukemia (ALL) who have developed hypersensitivity to E. coli-derived asparaginase.2011-11-18T00:00:00-05:00http://www.ons.org/news.aspx?id=178http://www.ons.org/News.aspx?id=177Legislative UpdatesPresident Obama: Congratulations to Everyone Taking Part in Today's Great American Smokeout.2011-11-18T00:00:00-05:00http://www.ons.org/news.aspx?id=177http://www.ons.org/News.aspx?id=179FDA UpdatesThe US Food and Drug Administration approved ruxolitinib (Jakafi oral tablets, Incyte Corporation) for the treatment of intermediate and high risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis. 2011-11-16T00:00:00-05:00http://www.ons.org/news.aspx?id=179http://www.ons.org/News.aspx?id=173FDA UpdatesThe US Food and Drug Administration approved cetuximab (Erbitux®, ImClone LLC, a wholly-owned subsidiary of Eli-Lilly and Company) in combination with platinum-based therapy plus 5-florouracil (5-FU) for the first-line treatment of patients with recurrent locoregional disease and/or metastatic squamous cell carcinoma of the head and neck (SCCHN).2011-11-07T00:00:00-05:00http://www.ons.org/news.aspx?id=173http://www.ons.org/News.aspx?id=174Legislative UpdatesNIH researchers created a light-based therapy that targets and destroys certain tumors and cancers in mice, according to the NCI. 2011-11-07T00:00:00-05:00http://www.ons.org/news.aspx?id=174http://www.ons.org/News.aspx?id=180ONS NewsThe Oncology Nursing Society (ONS) announces that its Research Agenda, which focuses on gaps in the knowledge base for oncology nursing practice, was updated in 2011.2011-10-28T00:00:00-04:00http://www.ons.org/news.aspx?id=180http://www.ons.org/News.aspx?id=172ONS NewsThe CDC has released a new program called Preventing Infections in Cancer Patients. The program consists of two new tools for patients, their caregivers, and their healthcare providers.2011-10-25T00:00:00-04:00http://www.ons.org/news.aspx?id=172http://www.ons.org/News.aspx?id=171Legislative UpdatesMelanoma skin cancer has a costly and deadly impact on America. The CDC releases the most comprehensive melanoma report in the United States to date.2011-10-19T00:00:00-04:00http://www.ons.org/news.aspx?id=171http://www.ons.org/News.aspx?id=170FDA UpdatesThe US Food and Drug Administration granted accelerated approval to deferiprone (Ferriprox® Tablets, ApoPharma, Inc.), an oral iron chelator for the treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate.2011-10-14T00:00:00-04:00http://www.ons.org/news.aspx?id=170http://www.ons.org/News.aspx?id=167Legislative UpdatesRead a statement from Secretary Sebilius about National Breast Cancer Awareness Month.2011-10-06T00:00:00-04:00http://www.ons.org/news.aspx?id=167http://www.ons.org/News.aspx?id=169Legislative UpdatesOctober is National Breast Cancer Awareness Month – a time to remember those who have lost their lives to breast cancer and those who are battling it now, and to celebrate with those who have survived. It is also a time to reaffirm our commitment to fighting breast cancer and to remind ourselves of the importance of prevention and early detection. 2011-10-06T00:00:00-04:00http://www.ons.org/news.aspx?id=169http://www.ons.org/News.aspx?id=165FDA UpdatesChanges in bevacizumab (Avastin®, Genentech, Inc.) package insert regarding: risk of ovarian failure, osteonecrosis of the jaw, risk of venous thromboembolic event (VTE) and bleeding in patients receiving anticoagulation therapy after first VTE event.2011-10-03T00:00:00-04:00http://www.ons.org/news.aspx?id=165http://www.ons.org/News.aspx?id=164FDA Updatesthe U.S. Food and Drug Administration (FDA) granted accelerated approval for the use of eculizumab (Soliris®, Alexion, Inc.) for the treatment of pediatric and adult patients with atypical hemolytic uremic syndrome (aHUS). 2011-09-23T00:00:00-04:00http://www.ons.org/news.aspx?id=164http://www.ons.org/News.aspx?id=162ONS NewsThe ONS Board of Directors approved a new set of guiding principles for corporate support and conflicts of interest (COIs) that is designed to provide a framework for relationships and interactions between ONS and for-profit organizations. 2011-09-20T00:00:00-04:00http://www.ons.org/news.aspx?id=162http://www.ons.org/News.aspx?id=163ONS NewsAfter conducting a thorough scan of the oncology healthcare environment, the Oncology Nursing Society (ONS) developed a new five-year strategic plan, which will take effect in 2012. 2011-09-20T00:00:00-04:00http://www.ons.org/news.aspx?id=163http://www.ons.org/News.aspx?id=161ONS NewsDuring its July 2011 Board meeting, the ONS Board of Directors conducted a thorough review of Society’s current position statements and noted that some of the current positions no longer speak to a perspective unique to ONS, may no longer be relevant, or are now common practice. As a result, some positions will be revised, some will be combined together and retitled, and others will be archived as they currently stand, with possible key components incorporated into other positions as applicable. 2011-09-20T00:00:00-04:00http://www.ons.org/news.aspx?id=161http://www.ons.org/News.aspx?id=176ONS NewsThe ONS Leadership Development Institute (LDI) was held annually from 1998–2010. Although the program was well received, the number of nurses participating was limited each year. In response to the current economic climate, the ONS Board of Directors and staff decided to step back and re-evaluate the program, as well as define the leadership needs of the ONS membership and the organization as a whole. 2011-09-20T00:00:00-04:00http://www.ons.org/news.aspx?id=176http://www.ons.org/News.aspx?id=157FDA UpdatesThe US Food and Drug Administration granted approval for denosumab (Prolia®, Amgen Inc.) as a treatment to increase bone mass in patients at high risk for fracture receiving androgen deprivation therapy (ADT) for nonmetastatic prostate cancer or adjuvant aromatase inhibitor (AI) therapy for breast cancer. In men with nonmetastatic prostate cancer, denosumab also reduced the incidence of vertebral fracture.2011-09-16T00:00:00-04:00http://www.ons.org/news.aspx?id=157http://www.ons.org/News.aspx?id=160ONS NewsTogether with the American Cancer Society, ONS cosponsored a special supplement that focuses on the importance of patient navigation. 2011-09-16T00:00:00-04:00http://www.ons.org/news.aspx?id=160http://www.ons.org/News.aspx?id=158Legislative UpdatesA new report shows a continuing decline in rates of new lung cancer cases among men, and a promising decline among women. 2011-09-15T00:00:00-04:00http://www.ons.org/news.aspx?id=158http://www.ons.org/News.aspx?id=156ONS NewsNurses from across the country gathered for the Oncology Nursing Society’s (ONS) Radiation eConference: Radiation Then and Now, and they never had to leave their hometowns. The Radiation eConference is ONS’s first all virtual event. 2011-09-12T00:00:00-04:00http://www.ons.org/news.aspx?id=156http://www.ons.org/News.aspx?id=154Legislative UpdatesThe CDC releases a new report on smoking. While heavy smoking decreases, light smoking increases. 2011-09-07T00:00:00-04:00http://www.ons.org/news.aspx?id=154http://www.ons.org/News.aspx?id=155ONS NewsUnintentional exposure to hazardous agents such as chemotherapy may endanger the lives of healthcare workers. The Oncology Nursing Society (ONS) offers resources designed to educate nurses on safe handling procedures.2011-09-07T00:00:00-04:00http://www.ons.org/news.aspx?id=155http://www.ons.org/News.aspx?id=152ONS NewsThe Nurse in Washington Internship (NIWI) Program is an annual event sponsored by the Nursing Organizations Alliance. The purpose of the NIWI Program is to provide nurses the opportunity to learn how to influence health care through legislative and regulatory processes. Participants learn from health policy experts and government officials and network with other nurses. The next NIWI is scheduled to be held February 26–28, 2012, in Washington, DC. This year, ONS is offering a limited number of grants for nurses to attend NIWI. The deadline to apply for the grant is November 1, 2011. Recipients of the grants will receive full registration for NIWI, expenses for travel and hotel, and a per diem.2011-09-02T00:00:00-04:00http://www.ons.org/news.aspx?id=152http://www.ons.org/News.aspx?id=151Legislative UpdatesScientists have found that individuals who carry a mutation in a gene called BAP1 are susceptible to developing two forms of cancer -- mesothelioma, and melanoma of the eye. Additionally, when these individuals are exposed to asbestos or similar mineral fibers, their risk of developing mesothelioma, an aggressive cancer of the lining of the chest and abdomen, may be markedly increased2011-08-29T00:00:00-04:00http://www.ons.org/news.aspx?id=151http://www.ons.org/News.aspx?id=150FDA UpdatesThe US Food and Drug Administration granted accelerated approval to crizotinib (XALKORI® Capsules, Pfizer Inc.) for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test. 2011-08-26T00:00:00-04:00http://www.ons.org/news.aspx?id=150http://www.ons.org/News.aspx?id=149FDA UpdatesThe US Food and Drug Administration granted accelerated approval to brentuximab vedotin (Adcetris™ for Injection, Seattle Genetics, Inc.) for two indications: • The treatment of patients with Hodgkin lymphoma after failure of autologous stem cell transplant (ASCT) or after failure of at least two prior multi-agent chemotherapy regimens in patients who are not ASCT candidates. • The treatment of patients with systemic anaplastic large cell lymphoma (ALCL) after failure of at least one prior multi-agent chemotherapy regimen. 2011-08-19T00:00:00-04:00http://www.ons.org/news.aspx?id=149http://www.ons.org/News.aspx?id=148FDA UpdatesThe US Food and Drug Administration approved vemurafenib tablets (ZELBORAFTM, Hoffmann-La Roche Inc.) for the treatment of patients with unresectable or metastatic melanoma with the BRAFV600E mutation as detected by an FDA-approved test. 2011-08-17T00:00:00-04:00http://www.ons.org/news.aspx?id=148http://www.ons.org/News.aspx?id=147Legislative UpdatesNIH study confirms bladder cancer risk from smoking is higher than previously estimated.2011-08-16T00:00:00-04:00http://www.ons.org/news.aspx?id=147http://www.ons.org/News.aspx?id=146Legislative UpdatesThe Department of Health and Human Services announces $71.3 million in nursing workforce grants to support training, diversity, and nursing faculty.2011-07-29T00:00:00-04:00http://www.ons.org/news.aspx?id=146http://www.ons.org/News.aspx?id=145ONS NewsThe Oncology Nursing Society (ONS) is pleased to announce that the Clinical Journal of Oncology Nursing (CJON), an award-winning publication of ONS, has been accepted for indexing in Web of ScienceSM, the largest and most comprehensive citation index available. 2011-07-20T00:00:00-04:00http://www.ons.org/news.aspx?id=145http://www.ons.org/News.aspx?id=144Awards GrantedJill Hamilton, PhD, RN, is the recipient of the Oncology Nursing Society (ONS) Publishing Division’s Excellence in Writing Award for Qualitative Nursing Research.2011-07-14T00:00:00-04:00http://www.ons.org/news.aspx?id=144http://www.ons.org/News.aspx?id=143ONS NewsThe Oncology Nursing Society (ONS) was recently honored with several awards for its publishing excellence. 2011-07-06T00:00:00-04:00http://www.ons.org/news.aspx?id=143http://www.ons.org/News.aspx?id=142Legislative UpdatesThe CDC released a report on colorectal cancer with current data on colorectal cancer screening, incidence, and mortality.2011-07-05T00:00:00-04:00http://www.ons.org/news.aspx?id=142http://www.ons.org/News.aspx?id=140ONS NewsAs a leading force in the drive to bring the highest quality care to all patients, the Oncology Nursing Society (ONS) hosted a multidisciplinary dialogue on measuring care at its headquarters this week. 2011-06-29T00:00:00-04:00http://www.ons.org/news.aspx?id=140http://www.ons.org/News.aspx?id=139Legislative UpdatesThe U.S. Food and Drug Administration (FDA) today unveiled the nine graphic health warnings required to appear on every pack of cigarettes sold in the United States and in every cigarette advertisement. 2011-06-21T00:00:00-04:00http://www.ons.org/news.aspx?id=139http://www.ons.org/News.aspx?id=137Legislative UpdatesEncourage your representative in Congress to become a member of the House Nursing Caucus.2011-06-16T00:00:00-04:00http://www.ons.org/news.aspx?id=137http://www.ons.org/News.aspx?id=135Legislative UpdatesThe life-threatening nature of cancer and the complexity of cancer treatment options, each with its own set of potential risks and benefits, make it difficult for people with cancer to make decisions about their care. 2011-06-15T00:00:00-04:00http://www.ons.org/news.aspx?id=135http://www.ons.org/News.aspx?id=136FDA UpdatesThe Food and Drug Administration (FDA) is taking steps to help protect consumers from skin damage caused by excessive sun exposure.2011-06-15T00:00:00-04:00http://www.ons.org/news.aspx?id=136http://www.ons.org/News.aspx?id=133Legislative UpdatesONS submitted formal testimony to the NIH regarding prescription medication. 2011-06-07T00:00:00-04:00http://www.ons.org/news.aspx?id=133http://www.ons.org/News.aspx?id=130Awards GrantedThe Oncology Nursing Certification Corporation (ONCC) has selected Marcelle Kaplan, RN, MS, AOCN®, CBCN® as the 2011 Advanced Oncology Certified Nurse of the Year. Kaplan won the award for her significant contributions to oncology nursing and oncology nursing service and for supporting and promoting certification in oncology nursing. 2011-06-03T00:00:00-04:00http://www.ons.org/news.aspx?id=130http://www.ons.org/News.aspx?id=129Awards GrantedThe Oncology Nursing Certification Corporation (ONCC) has selected Maureen O’Hara, RN, BSN, OCN® as the 2011 Oncology Certified Nurse of the Year. O’Hara was selected for the award for her contributions to oncology nursing and oncology nursing service and for supporting and promoting certification in oncology nursing. 2011-06-03T00:00:00-04:00http://www.ons.org/news.aspx?id=129http://www.ons.org/News.aspx?id=131Awards GrantedThe Oncology Nursing Certification Corporation (ONCC) has selected Springfield Oncology Hematology Associates (OHA) in Springfield, MO, as a recipient of its 2011 Employer Recognition Award. Each year this award recognizes one organization that employs less than 25 registered nurses for providing sustained support of oncology nursing certification. 2011-06-03T00:00:00-04:00http://www.ons.org/news.aspx?id=131http://www.ons.org/News.aspx?id=132Awards GrantedThe Oncology Nursing Certification Corporation (ONCC) has selected Georgetown University Hospital, as a recipient of its 2011 Employer Recognition Award. Each year this award recognizes one organization that employs 25 or more registered nurses for their sustained support of oncology nursing certification. 2011-06-03T00:00:00-04:00http://www.ons.org/news.aspx?id=132http://www.ons.org/News.aspx?id=128Awards GrantedThe Oncology Nursing Certification Corporation (ONCC) has selected Susan Bowman, RN, OCN®, CBCN®, MSW as the 2011 Certified Breast Care Nurse of the Year.2011-06-03T00:00:00-04:00http://www.ons.org/news.aspx?id=128http://www.ons.org/News.aspx?id=125Awards GrantedLaurie Dohnalek, RN, MBA, NE-BC, is the recipient of the 2011 Oncology Nursing Society (ONS) Excellence in Oncology Nursing Health Policy and Advocacy Award. This award recognizes and supports her achievements and involvement in oncology nursing health policy and advocacy. 2011-05-25T00:00:00-04:00http://www.ons.org/news.aspx?id=125http://www.ons.org/News.aspx?id=123FDA UpdatesThe US Food and Drug Administration approved sunitinib (Sutent® Capsules, Pfizer, Inc.) for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors (pNET) in patients with unresectable, locally advanced, or metastatic disease. 2011-05-24T00:00:00-04:00http://www.ons.org/news.aspx?id=123http://www.ons.org/News.aspx?id=122Legislative UpdatesONS Health Policy Director Alec Stone congratulates ONS member and 2011 Advocacy Award winner Laurie J. Dohnalek, RN, MBA, NE-BC after receiving her plaque for outstanding contributions in oncology nursing health policy advocacy.2011-05-20T00:00:00-04:00http://www.ons.org/news.aspx?id=122http://www.ons.org/News.aspx?id=118Legislative UpdatesThe Oncology Nursing Society (ONS) joined the U.S. Department of Health and Human Services along with hospitals, healthcare providers, and other organizations in the Partnership for Patients to make hospital care safer, more reliable, and less costly.2011-05-19T00:00:00-04:00http://www.ons.org/news.aspx?id=118http://www.ons.org/News.aspx?id=116Legislative UpdatesKathleen Sebelius, secretary of the U.S. Department of Health and Human Services, recognized the contributions of nurses and thanked them for their critical work in an official statement released in honor of National Nurses Week. 2011-05-12T00:00:00-04:00http://www.ons.org/news.aspx?id=116http://www.ons.org/News.aspx?id=115FDA UpdatesThe U.S. Food and Drug Administration approved everolimus (Afinitor® Tablets, Novartis Pharmaceuticals Corporation), for the treatment of progressive neuroendocrine tumors of pancreatic origin (PNET) in patients with unresectable, locally advanced or metastatic disease. 2011-05-05T00:00:00-04:00http://www.ons.org/news.aspx?id=115http://www.ons.org/News.aspx?id=113Legislative UpdatesWith the concern about the future implementation of the Patient Protection and Affordable Care Act (PPACA) and the current economic environment, ONS has joined a number of other cancer organizations in raising Congress's awareness of the importance of a key prevention and detection fund included in the original legislation. 2011-05-04T00:00:00-04:00http://www.ons.org/news.aspx?id=113http://www.ons.org/News.aspx?id=110ONS NewsThe Oncology Nursing Society (ONS) announced its 2011–2012 Board of Directors at its 36th Annual Congress in Boston, MA. 2011-04-30T00:00:00-04:00http://www.ons.org/news.aspx?id=110http://www.ons.org/News.aspx?id=108ONS NewsThe Oncology Nursing Society (ONS) has joined the Journey Forward collaborative to promote cancer survivorship through the use of Survivorship Care Plans.2011-04-28T00:00:00-04:00http://www.ons.org/news.aspx?id=108http://www.ons.org/News.aspx?id=106Awards GrantedJudith Johnson, PhD, RN, FAAN, is the recipient of the 2011 Oncology Nursing Society (ONS) Lifetime Achievement Award. The award recognizes her outstanding contributions as an oncology nurse researcher, mentor, and educator as well as her service to ONS and the community at large. 2011-04-25T00:00:00-04:00http://www.ons.org/news.aspx?id=106http://www.ons.org/News.aspx?id=107Awards GrantedMartha Langhorne, MSN, RN, FNP, AOCN®, is the 2011 recipient of the Oncology Nursing Society (ONS) Pearl Moore Making a Difference Award. The award recognizes her significant contributions to the oncology nursing profession at the local and regional levels2011-04-25T00:00:00-04:00http://www.ons.org/news.aspx?id=107http://www.ons.org/News.aspx?id=102ONS NewsThe Oncology Nursing Society (ONS) has hired Elizabeth Wertz Evans, RN, BSN, MPM, FACMPE, CPHQ, CPHIMS, to serve as executive director of professional practice and programs. She will lead ONS’s division that oversees education, publishing, research, library/archives, and international initiatives.2011-04-19T00:00:00-04:00http://www.ons.org/news.aspx?id=102http://www.ons.org/News.aspx?id=104Legislative UpdatesONS member Patrick Coyne, MSN, APN, FAAN, was a witness and testified on behalf of the broad patient and provider communities regarding pain relief at a hearing "Warning: The Growing Danger of Prescription Drug Diversion." 2011-04-14T00:00:00-04:00http://www.ons.org/news.aspx?id=104http://www.ons.org/News.aspx?id=101FDA UpdatesThe U. S. Food and Drug Administration approved vandetanib tablets (Vandetanib Tablets, AstraZeneca Pharmaceuticals LP), a kinase inhibitor, for the treatment of symptomatic or progressive medullary thyroid cancer in patients with unresectable, locally advanced, or metastatic disease. The use of vandetanib in patients with indolent, asymptomatic or slowly progressing disease should be carefully considered because of the treatment-related risks of vandetanib. 2011-04-12T00:00:00-04:00http://www.ons.org/news.aspx?id=101http://www.ons.org/News.aspx?id=100ONS NewsThe ONS Board of Directors approved some exciting new changes to ONS’s national conference offerings at its March 2011 meeting. These changes are in direct response to customer feedback and the changing landscape of healthcare meetings and education.2011-04-11T00:00:00-04:00http://www.ons.org/news.aspx?id=100http://www.ons.org/News.aspx?id=99ONS NewsONS’s Putting Evidence Into Practice (PEP®) guidelines are now included in the National Guideline Clearinghouse (NGC), an initiative of the U.S. Department of Health and Human Services’ Agency for Healthcare Research and Quality (AHRQ).2011-04-04T00:00:00-04:00http://www.ons.org/news.aspx?id=99http://www.ons.org/News.aspx?id=96FDA UpdatesThe U.S. Food and Drug Administration approved peginterferon alfa-2b (Sylatron™, Schering Corporation, Kenilworth, NJ 07033), for the treatment of patients with melanoma with microscopic or gross nodal involvement within 84 days of definitive surgical resection including complete lymphadenectomy.2011-03-29T00:00:00-04:00http://www.ons.org/news.aspx?id=96http://www.ons.org/News.aspx?id=95FDA UpdatesThe U. S. Food and Drug Administration approved ipilimumab injection (YERVOY ®, Bristol-Myers Squibb Company) for the treatment of unresectable or metastatic melanoma. 2011-03-25T00:00:00-04:00http://www.ons.org/news.aspx?id=95http://www.ons.org/News.aspx?id=105Awards GrantedDavid Makumi-Kinyanjui, RN, MPC(c), is the 2011 recipient of the Oncology Nursing Society (ONS) International Award for Contributions to Cancer Care. The award recognizes his contribution in drawing the attention of the country to the cancer crisis and his leadership in empowering nurses and ordinary Kenyans with knowledge and skills to respond to the growing cancer problem. 2011-03-24T00:00:00-04:00http://www.ons.org/news.aspx?id=105http://www.ons.org/News.aspx?id=92Awards GrantedDonna L. Berry, PhD, RN, AOCN®, FAAN, has been named the Oncology Nursing Society’s (ONS) 2011 Distinguished Researcher. 2011-03-17T00:00:00-04:00http://www.ons.org/news.aspx?id=92http://www.ons.org/News.aspx?id=91ONS NewsThe Oncology Nursing Society (ONS) has developed a number of tactics that address the key messages identified in the Institute of Medicine (IOM) Report on the Future of Nursing, which was published in October 2010. 2011-03-08T00:00:00-05:00http://www.ons.org/news.aspx?id=91http://www.ons.org/News.aspx?id=98Awards GrantedMarie Anne Bakitas, DNSc, APRN, NP-C, AOCN®, ACHPN, FAAN, was presented the Oncology Nursing Society (ONS) 2011 Victoria Mock New Investigator Award today at the ONS 11th National Conference on Cancer Nursing Research in Los Angeles, CA.2011-02-12T00:00:00-05:00http://www.ons.org/news.aspx?id=98http://www.ons.org/News.aspx?id=97Awards GrantedDonald Bailey, Jr., PhD, RN, presented the 2011 Oncology Nursing Society (ONS) State-of-the-Science Lecture, “Illness Uncertainty in Adult Cancer Patients,” today during the ONS 11th National Conference on Cancer Nursing Research in Los Angeles.2011-02-11T00:00:00-05:00http://www.ons.org/news.aspx?id=97http://www.ons.org/News.aspx?id=86Press ReleasesYoung African American women at high risk for breast cancer described the risk itself as a life-changing experience, according to a study released today at the Oncology Nursing Society (ONS) 11th National Conference on Cancer Nursing Research. 2011-02-11T00:00:00-05:00http://www.ons.org/news.aspx?id=86http://www.ons.org/News.aspx?id=88ONS NewsA study published Wednesday in JAMA found that, among a small subset of patients with breast cancer, axillary dissection in patients with sentinel node metastases does not significantly affect survival rates. The study was covered by the mainstream media with a New York Times’ reporter describing it as turning “standard medical practice on its head.” Although the findings are exciting for breast cancer patients, nurses play a key role in helping patients understand the limitations of the findings.2011-02-11T00:00:00-05:00http://www.ons.org/news.aspx?id=88http://www.ons.org/News.aspx?id=87Press ReleasesPatients with lung cancer, whether they smoke or not, feel stigmatized because their disease is strongly associated with smoking, according to a study released today at the Oncology Nursing Society (ONS) 11th National Conference on Cancer Nursing Research.2011-02-11T00:00:00-05:00http://www.ons.org/news.aspx?id=87http://www.ons.org/News.aspx?id=85ONS NewsAn estimated 12 million people are cancer survivors, yet only 27% of nurses working in oncology report that their practice has a formal survivorship program.2011-02-08T00:00:00-05:00http://www.ons.org/news.aspx?id=85http://www.ons.org/News.aspx?id=84FDA Updatesthe U.S. Food and Drug Administration approved rituximab (Rituxan®, Genentech, Inc) for maintenance therapy for patients with previously untreated follicular, CD-20 positive, B-cell non-Hodgkin lymphoma who achieve a response to rituximab in combination with chemotherapy. 2011-01-28T00:00:00-05:00http://www.ons.org/news.aspx?id=84http://www.ons.org/News.aspx?id=81ONS NewsThe Oncology Nursing Society (ONS) has joined leading cancer advocacy groups and professional associations to support an education and awareness platform around cancer survivorship through a holiday television special called Kaleidoscope on Ice. 2010-12-17T00:00:00-05:00http://www.ons.org/news.aspx?id=81http://www.ons.org/News.aspx?id=80ONS NewsFor many years, the ONS Leadership Development Institute (LDI) has brought together hundreds of participants from a variety of backgrounds for a three-day leadership conference followed by a year of mentorship and goal accomplishment. Due to changing needs, the decision has been made to take a step back from our current LDI program in 2011 and allow for a period of assessment and reflection. Therefore, ONS will not offer LDI in 2011. We look forward to a continued tradition of excellence in leadership programming that will address the needs of nurses in the future. 2010-12-08T00:00:00-05:00http://www.ons.org/news.aspx?id=80http://www.ons.org/News.aspx?id=79ONS NewsOf all the nominations received for Honor Someone Special, no one has been named more than Mary Diffendall, RN, OCN®. Mary, an oncology nurse at Connecticut Oncology Group in Middletown, has been nominated for Honor Someone Special 26 times, often by her patients. Here is what is being said about Mary.2010-12-08T00:00:00-05:00http://www.ons.org/news.aspx?id=79http://www.ons.org/News.aspx?id=78FDA UpdatesThe U.S. Food and Drug Administration granted approval for denosumab (Xgeva™, Amgen Inc.) for the prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumors. Denosumab is not indicated for the prevention of SREs in patients with multiple myeloma.2010-11-18T00:00:00-05:00http://www.ons.org/news.aspx?id=78http://www.ons.org/News.aspx?id=71FDA UpdatesThe US Food and Drug Administration granted approval for eribulin mesylate (Halaven™ Injection, Eisai Inc.) for the treatment of patients with metastatic breast cancer who have previously received an anthracycline and a taxane in either the adjuvant or metastatic setting, and at least two chemotherapeutic regimens for the treatment of metastatic disease. 2010-11-15T00:00:00-05:00http://www.ons.org/news.aspx?id=71http://www.ons.org/News.aspx?id=70FDA UpdatesThis notice is to inform you of important new safety information regarding the already labeled adverse reaction of oligohydramnios (decreased amniotic fluid). 2010-11-02T00:00:00-04:00http://www.ons.org/news.aspx?id=70http://www.ons.org/News.aspx?id=68FDA Updatesthe U.S. Food and Drug Administration granted accelerated approval to everolimus (Afinitor®, Novartis), an mTOR inhibitor, for patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS) who require therapy but are not candidates for surgical resection.2010-10-29T00:00:00-04:00http://www.ons.org/news.aspx?id=68http://www.ons.org/News.aspx?id=66ONS NewsIndustrial Scientific Corporation has signed a lease with the Oncology Nursing Society (ONS) in RIDC Park West. The 35,000-square foot Findlay Township location will serve as their primary development and commercial facility. The company’s corporate headquarters is located in Oakdale.2010-10-29T00:00:00-04:00http://www.ons.org/news.aspx?id=66http://www.ons.org/News.aspx?id=67FDA UpdatesThe U.S. Food and Drug Administration granted accelerated approval to dasatinib [Sprycel®, Bristol-Myers Squibb], an orally administered kinase inhibitor, for the treatment of newly diagnosed adult patients with Philadelphia chromosome positive chronic myeloid leukemia in chronic phase (CP-CML). 2010-10-28T00:00:00-04:00http://www.ons.org/news.aspx?id=67http://www.ons.org/News.aspx?id=65FDA UpdatesThe US Food and Drug Administration granted approval for trastuzumab (Herceptin®), Genentech, Inc.), in combination with cisplatin and a fluoropyrimidine (capecitabine or 5-fluorouracil), for the treatment of patients with HER2 overexpressing metastatic gastric or gastroesophageal (GE) junction adenocarcinoma, who have not received prior treatment for metastatic disease. 2010-10-20T00:00:00-04:00http://www.ons.org/news.aspx?id=65http://www.ons.org/News.aspx?id=62Legislative UpdatesAt 6:30 pm October 14, the White House was bathed in a soft pink light to make a public statement about breast cancer awareness month. 2010-10-14T00:00:00-04:00http://www.ons.org/news.aspx?id=62http://www.ons.org/News.aspx?id=64FDA UpdatesRecent changes in the measurement of serum creatinine may have an impact on carboplatin dosing.2010-10-08T00:00:00-04:00http://www.ons.org/news.aspx?id=64http://www.ons.org/News.aspx?id=47Legislative UpdatesThe Nurse in Washington Internship (NIWI) Program is an annual event sponsored by the Nursing Organizations Alliance (The Alliance). With over 60 member organizations, ONS among them, The Alliance represents approximately 500,000 nurses. The Alliance sponsors the internship to promote the interests of its member groups through education, research, and health-policy activities. Over the years, more than one thousand nurses have attended NIWI, many of whom have become influential participants in the political process at state and federal levels.2010-10-07T00:00:00-04:00http://www.ons.org/news.aspx?id=47http://www.ons.org/News.aspx?id=46Legislative UpdatesThe Institute of Medicine’s latest consensus report on the “The Future of Nursing: Leading Change, Advancing Health” provides support for the crucial role of nursing in addressing the increased demand for services expected from healthcare reform legislation. 2010-10-07T00:00:00-04:00http://www.ons.org/news.aspx?id=46http://www.ons.org/News.aspx?id=45Awards Granted2010-09-30T00:00:00-04:00http://www.ons.org/news.aspx?id=45http://www.ons.org/News.aspx?id=44Press ReleasesThe Oncology Nursing Society (ONS) was honored by the Web Marketing Association with awards for their website excellence. 2010-09-30T00:00:00-04:00http://www.ons.org/news.aspx?id=44http://www.ons.org/News.aspx?id=42Press ReleasesPITTSBURGH, PA – September 24, 2010 – Three ONS members have been named to the list of the top 10 most influential nursing professors by the Mister Medicine blog. 2010-09-24T00:00:00-04:00http://www.ons.org/news.aspx?id=42http://www.ons.org/News.aspx?id=61Legislative UpdatesThe Health Resources and Services Administration (HRSA) recently presented a report showing that the nursing workforce increased by more than 5% between 2004 and 2008.2010-09-22T00:00:00-04:00http://www.ons.org/news.aspx?id=61http://www.ons.org/News.aspx?id=51Legislative UpdatesThe United States Senate rejected Senator Mike Johanns’ (R-NE) amendment to the Small Business Jobs and Credit Act. 2010-09-13T00:00:00-04:00http://www.ons.org/news.aspx?id=51http://www.ons.org/News.aspx?id=38ONS NewsONS prepares for the 11th Annual Institutes of Learning and ONS Advanced Practice Nursing Conferences in Orlando.2010-08-12T00:00:00-04:00http://www.ons.org/news.aspx?id=38http://www.ons.org/News.aspx?id=35Press ReleasesPITTSBURGH, PA – July 30, 2010 – The Oncology Nursing Society (ONS) is pleased to announce its sponsorship of the Institute of Medicine’s (IOM) National Cancer Policy Forum. The Forum explores emerging policy issues in the nation’s effort to combat cancer and enables all members to be full participants in identifying and debating critical issues and examining potential actions.2010-07-30T00:00:00-04:00http://www.ons.org/news.aspx?id=35http://www.ons.org/News.aspx?id=34Legislative UpdatesPITTSBURGH, PA – July 26, 2010 – Oncology Nursing Society (ONS) President Carlton Brown, RN, PhD, AOCN®, testified before a U.S. Food and Drug Administration (FDA) committee in Washington, DC, regarding the proposed Risk Evaluation and Mitigation Strategies (REMS) for Extended-Release and Long-Acting Opioid Analgesics, which seeks to address the issue of opioid misuse and abuse. The CoC has replied to the letter, indicating that it intends to take some of ONS’s suggestions.2010-07-26T00:00:00-04:00http://www.ons.org/news.aspx?id=34http://www.ons.org/News.aspx?id=49Legislative UpdatesView slide presentation from the 2010 ONS Mentorship session.2010-07-17T00:00:00-04:00http://www.ons.org/news.aspx?id=49http://www.ons.org/News.aspx?id=33Press ReleasesPITTSBURGH, PA – July 2, 2010 – The Oncology Nursing Society (ONS) is celebrating its 35th anniversary as a professional association providing membership benefits to more than 36,000 registered nurses who specialize in caring for patients with cancer.2010-07-02T00:00:00-04:00http://www.ons.org/news.aspx?id=33http://www.ons.org/News.aspx?id=39FDA UpdatesOn June 21, 2010, Pfizer Inc., in agreement with the FDA, announced that the commercial marketing of Mylotarg (gemtuzumab ozogamicin) will be voluntarily discontinued, and the new drug application (NDA) for Mylotarg will be withdrawn as of October 15, 2010.2010-06-21T00:00:00-04:00http://www.ons.org/news.aspx?id=39http://www.ons.org/News.aspx?id=41FDA UpdatesOn June 17, 2010, the U.S. Food and Drug Administration (FDA) approved cabazitaxel (Jevtana® Injection, sanofi-aventis) for use in combination with prednisone for treatment of patients with metastatic hormone-refractory prostate cancer (mHRPC) previously treated with a docetaxel-containing regimen.2010-06-17T00:00:00-04:00http://www.ons.org/news.aspx?id=41http://www.ons.org/News.aspx?id=40FDA UpdatesOn June 17, 2010, the U. S. Food and Drug Administration granted accelerated approval to nilotinib (Tasigna® Capsules, Novartis Pharmaceuticals Corporation), an orally administered kinase inhibitor, for the treatment of adult patients with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP-CML). 2010-06-17T00:00:00-04:00http://www.ons.org/news.aspx?id=40http://www.ons.org/News.aspx?id=32Press ReleasesPITTSBURGH, PA – June 15, 2010 – The Oncology Nursing Society (ONS) was honored by the Association Media and Publishing as a winner of the esteemed EXCEL Award in two categories at its recent 30th Annual EXCEL Awards Gala in Washington, DC.2010-06-15T00:00:00-04:00http://www.ons.org/news.aspx?id=32http://www.ons.org/News.aspx?id=30ONS NewsThe Oncology Nursing Society’s (ONS’s) long-standing efforts to support clinical trials funding and access to participation are in line with recommendations offered in the Institute of Medicine’s (IOM’s) recent report on the Cooperative Group Program and the American Society of Clinical Oncology’s (ASCO’s) response to the report.2010-05-28T00:00:00-04:00http://www.ons.org/news.aspx?id=30http://www.ons.org/News.aspx?id=48Legislative UpdatesCongressional Democrats today unveiled the outline of a bill that would delay a 21% cut in Medicare reimbursement to physicians until 2014 and increase rates for the rest of 2010 as well as 2011. 2010-05-20T00:00:00-04:00http://www.ons.org/news.aspx?id=48http://www.ons.org/News.aspx?id=31Press ReleasesSAN DIEGO, CA – May 15, 2010 – The Oncology Nursing Society (ONS) announced its 2010–2011 Board of Directors at its 35th Annual Congress in San Diego, CA.2010-05-15T00:00:00-04:00http://www.ons.org/news.aspx?id=31http://www.ons.org/News.aspx?id=36Awards GrantedSAN DIEGO, CA – May 13, 2010 – Connie Henke Yarbro, MS, RN, FAAN, of Destin, FL, is the recipient of the 2010 Oncology Nursing Society (ONS) Lifetime Achievement Award. Yarbro is the editor of Seminars in Oncology Nursing and an adjunct clinical associate professor at the University of Missouri-Columbia Sinclair School of Nursing. The award, presented today at the ONS 35th Annual Congress held in San Diego, CA, recognizes her outstanding contributions as an oncology nurse researcher, mentor, and educator as well as her service to ONS and the community at large. 2010-05-13T00:00:00-04:00http://www.ons.org/news.aspx?id=36http://www.ons.org/News.aspx?id=29Press ReleasesPITTSBURGH, PA – April 13, 2010 – The Oncology Nursing Society (ONS), the Association of Oncology Social Work (AOSW), and the National Association of Social Workers (NASW) worked together to develop a joint position statement on the role of oncology nursing and oncology social work in patient navigation.2010-04-13T00:00:00-04:00http://www.ons.org/news.aspx?id=29http://www.ons.org/News.aspx?id=52Legislative Updates2010-02-16T00:00:00-05:00http://www.ons.org/news.aspx?id=52http://www.ons.org/News.aspx?id=50Legislative UpdatesONS joined with others in the nursing community to advocate for nursing provisions. 2010-01-06T00:00:00-05:00http://www.ons.org/news.aspx?id=50http://www.ons.org/News.aspx?id=53Legislative Updates2009-09-10T00:00:00-04:00http://www.ons.org/news.aspx?id=53http://www.ons.org/News.aspx?id=54Legislative UpdatesONS submitted written comments to the Food and Drug Administration (FDA) related to the possibility that the FDA will create a Risk Evaluation and Mitigation Strategies (REMS) for certain opioid drugs.2009-06-26T00:00:00-04:00http://www.ons.org/news.aspx?id=54http://www.ons.org/News.aspx?id=55Legislative UpdatesThis is a synopsis of the testimony ONS delivered to the FDA on May 27th, 2009.2009-05-27T00:00:00-04:00http://www.ons.org/news.aspx?id=55http://www.ons.org/News.aspx?id=56Legislative UpdatesCommitment to Quality Health Reform: A Consensus Statement from the Nursing Community2009-05-01T00:00:00-04:00http://www.ons.org/news.aspx?id=56http://www.ons.org/News.aspx?id=57Legislative UpdatesHealth Policy Update April 20092009-04-01T00:00:00-04:00http://www.ons.org/news.aspx?id=57http://www.ons.org/News.aspx?id=58Legislative UpdatesPresident Obama signed the economic stimulus bill (H.R. 1) into law. 2009-02-17T00:00:00-05:00http://www.ons.org/news.aspx?id=58http://www.ons.org/News.aspx?id=59Legislative UpdatesCongress and the Centers for Medicare and Medicaid Services (CMS) took action to expand off-label cancer therapy coverage for Medicare beneficiaries2009-01-15T00:00:00-05:00http://www.ons.org/news.aspx?id=59http://www.ons.org/News.aspx?id=60Legislative UpdatesONS and US Oncology joined together to develop publication.2009-01-02T00:00:00-05:00http://www.ons.org/news.aspx?id=60